Strahlentherapie und Onkologie
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.8 | Q2 | 63.6% | 0.769 | Q2 | 76.0% |
| 2024 | 2.5 | Q2 | 62.1% | 0.692 | Q2 | 73.2% |
| 2023 | 2.7 | Q2 | 66.5% | 0.907 | Q1 | 83.1% |
| 2022 | 3.1 | Q2 | 68.3% | 0.885 | Q1 | 83.3% |
| 2021 | 4.0 | Q2 | 74.6% | 0.915 | Q1 | 84.6% |
| 2020 | — | — | 0.801 | Q2 | 79.8% | |
| 2019 | — | — | 0.909 | Q1 | 83.5% | |
| 2018 | — | — | 0.930 | Q1 | 82.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0179-7158
ISSN
1439-099X
country
DEcoverage
1986-2026